Suraksha Diagnostic Ltd

AI
Suraksha Diagno. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Suraksha Diagnostic Ltd

₹ 290 -2.69%
21 Oct - close price
surakshanet.com BSE: 544293 NSE: SURAKSHA
About

Incorporated in 2005, Suraksha Diagnostic offers an integrated pathology, radiology testing, and medical consultancy services solution.[1]

Key Points

Business Model:[1][2][3]
a) Integrated Services:
Offers a one-stop solution for pathology, radiology, and medical consultancy services.
b) Comprehensive Testing:
Provides 1,000+ pathology tests and 450+ radiology tests.
c) Hub and Spoke Model:
Operates through 1 Central Reference Lab, 7 Satellite Labs (co-located with hub centres), 16 Hub Centres, and 46 Spoke Centres (34 Small, 12 Medium, 6 PPP), with 193 Collection Centres and 4 Company Owned Collection Centres.
d) Omni-channel Consultation:
Combines online and offline medical consultation services, leveraging its polyclinics with 1,000+ doctors.
e) B2C-Focused Revenue Model:
Primarily serves individual patients,
with some revenue from B2B contracts.

Website BSE NSE
  • Market Cap ₹ 1,512 Cr.
  • Current Price ₹ 290
  • High / Low ₹ 360 / 224
  • Stock P/E 42.2
  • Book Value ₹ 47.0
  • Dividend Yield 0.17 %
  • ROCE 17.3 %
  • ROE 14.2 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company has delivered good profit growth of 31.8% CAGR over last 5 years

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Healthcare Service Provider

Part of BSE Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
60 52 55 61 67 60 65 73 79 78 81 88
39 36 36 40 44 41 46 49 55 55 57 57
Operating Profit 21 15 19 21 23 18 19 24 24 23 24 30
OPM % 35% 30% 35% 34% 35% 31% 29% 33% 31% 30% 30% 35%
1 1 0 1 1 1 1 1 1 1 1 1
Interest 2 2 2 2 2 2 2 3 3 3 4 4
Depreciation 8 8 8 9 9 9 9 9 10 11 11 11
Profit before tax 11 6 9 11 14 8 9 12 12 10 10 17
Tax % 24% 27% 32% 27% 26% 26% 22% 26% 27% 28% 38% 22%
8 5 6 8 10 6 7 9 9 7 6 13
EPS in Rs 1.95 1.08 1.51 1.84 2.40 1.18 1.42 1.80 1.73 1.44 1.21 2.50
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
158 140 223 190 219 252 310 325
123 115 174 143 146 170 214 223
Operating Profit 34 25 49 47 73 82 96 102
OPM % 22% 18% 22% 25% 33% 33% 31% 31%
2 -1 1 1 1 4 3 3
Interest 2 2 2 10 10 9 13 14
Depreciation 13 16 15 32 33 35 41 43
Profit before tax 21 6 33 7 31 41 45 49
Tax % 28% -1% 28% 10% 26% 25% 30%
15 6 24 6 23 31 31 35
EPS in Rs 3.53 1.49 5.51 1.51 5.48 6.11 6.18 6.88
Dividend Payout % 0% 0% 0% 0% 0% 0% 1%
Compounded Sales Growth
10 Years: %
5 Years: 17%
3 Years: 18%
TTM: 23%
Compounded Profit Growth
10 Years: %
5 Years: 32%
3 Years: 62%
TTM: 8%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -7%
Return on Equity
10 Years: %
5 Years: 14%
3 Years: 15%
Last Year: 14%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 7 7 7 7 7 10 10
Reserves 111 118 141 147 171 201 234
13 18 21 99 92 89 130
42 28 32 28 30 33 73
Total Liabilities 173 171 201 281 300 334 448
128 119 119 195 212 223 315
CWIP 0 0 1 2 1 11 37
Investments 5 5 0 0 0 1 0
39 46 80 84 87 99 97
Total Assets 173 171 201 281 300 334 448

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
31 24 42 44 60 63 82
-20 -28 -44 -21 -35 -40 -52
-10 3 1 -24 -25 -24 -29
Net Cash Flow 1 -1 -0 -1 0 -0 1
Free Cash Flow 15 8 23 32 18 21 15
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 111% 100% 95% 109% 95% 90% 99%

Ratios

Consolidated / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 14 16 12 9 15 20 27
Inventory Days 93 62 38 82 89 100 81
Days Payable 227 177 84 187 193 169 209
Cash Conversion Cycle -120 -99 -34 -96 -89 -49 -101
Working Capital Days -35 -19 -15 -49 -37 -23 -28
ROCE % 8% 24% 9% 17% 18% 17%

Insights

In beta
Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Number of Collection Centres
Number

Log in to view insights

Please log in to see hidden values.

Login
Number of Diagnostic Centres
Number
Number of Doctors (Radiologist & Pathologist)
Number
Number of Imaging Machines (MRI + CT)
Number
Number of Laboratories
Number
Number of Patients Served
Million patients
Number of Tests per Patient
Tests per patient
Number of Tests Performed
Million tests

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
48.78% 48.78% 48.89% 48.98% 49.00% 49.10% 49.10% 49.10%
15.39% 14.46% 13.95% 13.73% 13.46% 13.46% 13.47% 13.98%
20.43% 22.05% 22.37% 21.98% 22.57% 23.14% 23.22% 21.56%
15.39% 14.71% 14.79% 15.30% 14.98% 14.31% 14.20% 15.37%
No. of Shareholders 98,66287,27579,67075,30470,96367,10764,86660,792

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls